Palisade Bio Inc. (PALI)
NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PALI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $257.92M
- P/E (TTM)
- 2.47
- EPS (TTM)
- $0.60
- Dividend yield
- None
- 52-week range
- 1.32 – 2.86
- Day range
- 1.44 – 1.48
- Volume / Avg
- 825.23K / 2.64M
- Beta
- —
- Shares outstanding
- 174.27M
52-week range
PALI stock today
Shares of Palisade Bio (PALI) finished lower on Oct 7 at $1.48, a drop of 0.67% or $0.01 per share, versus the S&P 500's 0.22% decline. Trading was light, with 825.23K shares changing hands, about 31% of the average daily volume. At this level, PALI sits near the bottom of its 52-week range of $1.32 to $2.86: 48.3% below the high, set on Apr 22, 2026 and 12.1% above the low.
PALI is down 37.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 11.9%. Palisade Bio trades at 2.5x its trailing twelve-month earnings per share of $0.60.
Summary generated from market data by MetaCap's automated system. Methodology
About Palisade Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Carlsbad, CA
Palisade Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs PALI |
| SABSSAB Biotherapeutics Inc. | 2.88 | -1.71% | $262.04M | vs PALI |
| IKTInhibikase Therapeutics Inc. | 1.94 | -2.02% | $270.70M | vs PALI |
| LXEOLexeo Therapeutics Inc. | 3.31 | +0.30% | $271.71M | vs PALI |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs PALI |
| XFORX4 Pharmaceuticals Inc. | 2.81 | +1.44% | $278.60M | vs PALI |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs PALI |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs PALI |
Indexes, lists and sector
Palisade Bio stock FAQ
What is Palisade Bio's stock price today?
PALI last traded at $1.48 as of Oct 7, 4:00 PM EDT, down 0.67% on the day. Prices are delayed at least 15 minutes.
Does Palisade Bio pay a dividend?
No. Palisade Bio does not currently pay a regular cash dividend.
What is PALI's P/E ratio?
PALI trades at a trailing P/E ratio of 2.47.
Has PALI ever split its stock?
Yes. The most recent PALI stock split was a 1-for-15 split on Apr 8, 2024, one of 5 splits on record.
What is the PALI 52-week high?
The 52-week high for PALI is $2.86 and the 52-week low is $1.32. The stock is currently 48.3% below its high.